Senhwa Biosciences

Developer of small molecules for treating cancer

placeTaipei, Taipei, Taiwan calendar_todayFounded 2012 groups16 employees language senhwabio.com

Innovation

20 patent families (16 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace slowing. Cited 849 times.

YearFilings
20154
20164
20176
20184
20193
20205
20217
20228
20236
20243
20255
20261

Social engagement

Social engagement: 902 social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

3 investors on record.

Investor typeCountShare
Venture capital133%
Private equity133%
Other / undisclosed133%

Recent activity

23 Mar 2026
Partnership
CellType
17 Mar 2026
Recognition
3 Mar 2026
Partnership
Y Combinator
Coming soon